1Banchereau J,Palucka AK.Dendritic cells as therapeutic vaccines against cancer.Nat.Rev[J].Immunol,2005,5(2):296-306.
2Gilboa E,Nair SK,Lyerly HK.Immunotherapy of cancer with dendritic cell-based vaccines[J].Cancer Immunol.Immunother,1998,46(4):82-87.
3Cibotti R,Kanellopoulos JM,Cabaniols JP,et al.Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants[J].Proc.NatlAcad.Sci.USA,1992,89(1):416-420.
4Finn OJ.Cancer vaccines:between the idea and the reality[J].Nat.Rev.Immunol,2003,3(3):630-641.
5Tuyaerts S,Aerts JL,Corthals J,et al.Current approaches in dendritic cell generation and future implications for cancer immunotherapy[J].Cancer Immunol.Immunother,2007,56(2):1513-1537.
6Waldhauer I,Goehlsdorf D,Gieseke F,et al.Tumor-associated MICA is shed by ADAM proteases[J].Cancer Res,2008,68(6):6368-6376.
7Ribas A.Genetically modified dendritic cells for cancer immunotherapy[J].Curr.Gene Ther,2005,5(10):619-628.
8Breckpot K,Heirman C,Neyns B,Thielemans K.Exploiting dendritic cells for cancer immunotherapy:genetic modification of dendritic cells.J[J].Gene Med,2004,6(12):1175-1188.
4Novitskiy SV, Ryzhov S, Zaynagetdinov R, et al. Adenosine receptors in regulation of dendritic cell differentiation and function[J]. Blood, 2008,112(5): 1822-1831.
5Vander Most RG, Currie AJ, Robinson BW, et al. Decoding coding dangerous death: How cytotoxic chemotherapy invokes inflammation, immunity or nothing at all[J]. Cell Death Differ, 2008, 15:13-20.
6Friedrich MJ. Nobel prize honors immunity researchers[J]. JAVA,2011,306(18): 1966-1967.
7Hovden AO, Appel S. The first dendritic cell-based therapeutic cancer vaccine is approved by the FDA[J]. Scand J Immunol, 2010, 72(6): 554.
8Steinman RM, Banchereau J. Taking dendritic cells into medicine[J]. Nature, 2007,449(7161): 419-426.
9Avigan D, Rosenblatt J, Kufe D. Dendritic/Tumor fusion cells as cancer vaccines[J]. Semin 0ncoi, 2012,39(3): 287-295.
10Zloza A, Jagoda susceptibility of mediated suppressi 291-297. MC, Lyons GE, et al. CD8 co-receptor promotes CD8^+ T cells to transforming growth factor-β- on[J]. Cancer Imunol Imunother, 2011,60(2):.